$16.00
3.00[23.08%]
Last update: 9:24AM Get Real Time Here
Skye Bioscience
(NASDAQ:SKYE)Skye Bioscience Stock (NASDAQ:SKYE), Analyst Ratings, Price Targets, Predictions
Skye Bioscience Inc has a consensus price target of $22.5, established from looking at the 3 latest analyst ratings. The last 3 analyst ratings were released from Oppenheimer, Piper Sandler, and Piper Sandler on April 12, 2024, March 14, 2024, and February 5, 2024. With an average price target of $19 between Oppenheimer, Piper Sandler, and Piper Sandler, there's an implied 18.75% upside for Skye Bioscience Inc from these 3 analyst ratings.
Analyst Firms Making Recommendations1
Oppenheimer
Piper Sandler
1calculated from analyst ratings published within the last 3 years
Analyst Ratings for Skye Bioscience
date | ticker | Buy Now | Company | Current price | Upside/Downside | Analyst Firm | Analyst & % Accurate | Price Target Change | Rating Change | Previous / Current Rating | Get Alert |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 04/12/2024 | SKYE | Buy Now | Skye Bioscience | $16.00 | 56.25% | Oppenheimer | Jay Olson | → $25 | Initiates | → Outperform | Get Alert |
| 03/14/2024 | SKYE | Buy Now | Skye Bioscience | $16.00 | 25% | Piper Sandler | Edward Tenthoff | $12 → $20 | Reiterates | Overweight → Overweight | Get Alert |
| 02/05/2024 | SKYE | Buy Now | Skye Bioscience | $16.00 | -25% | Piper Sandler | Edward Tenthoff | → $12 | Initiates | → Overweight | Get Alert |
FAQ
What is the target price for Skye Bioscience (SKYE)?
The latest price target for Skye Bioscience (NASDAQ: SKYE) was reported by Oppenheimer on April 12, 2024. The analyst firm set a price target for $25.00 expecting SKYE to rise to within 12 months (a possible 56.25% upside). 3 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for Skye Bioscience (SKYE)?
The latest analyst rating for Skye Bioscience (NASDAQ: SKYE) was provided by Oppenheimer, and Skye Bioscience initiated their outperform rating.
When was the last upgrade for Skye Bioscience (SKYE)?
There is no last upgrade for Skye Bioscience.
When was the last downgrade for Skye Bioscience (SKYE)?
There is no last downgrade for Skye Bioscience.
When is the next analyst rating going to be posted or updated for Skye Bioscience (SKYE)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Skye Bioscience, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Skye Bioscience was filed on April 12, 2024 so you should expect the next rating to be made available sometime around April 12, 2025.
Is the Analyst Rating Skye Bioscience (SKYE) correct?
While ratings are subjective and will change, the latest Skye Bioscience (SKYE) rating was a initiated with a price target of $0.00 to $25.00. The current price Skye Bioscience (SKYE) is trading at is $16.00, which is within the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.